HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PLCB1 Enhances Cell Migration and Invasion in Gastric Cancer Via Regulating Actin Cytoskeletal Remodeling and Epithelial-Mesenchymal Transition.

Abstract
Phospholipase C Beta 1 (PLCB1) regulates the abundance of PI(4,5)P2 in the plasma membrane and is implicated in various kinds of cancers. This study aimed to investigate the role and underlying mechanisms of PLCB1 in gastric cancer. Herein, it was found that PLCB1 mRNA and protein were highly expressed in gastric cancer, and high levels of PLCB1 were correlated with poor outcomes of patients with gastric cancer via the GEPIA database. Moreover, our results revealed that PLCB1 depletion inhibited gastric cancer cell proliferation, migration, and invasion. Meanwhile, PLCB1 overexpression resulted in an inverse result. Furthermore, PLCB1 mediated actin cytoskeleton rearrangement and activated the RhoA/LIMK/Cofilin pathway. Besides, PLCB1 promoted the Epithelial-Mesenchymal transition process via activating ATK signaling. In conclusion, PLCB1 promoted gastric cancer cell migratory and invasive abilities via regulating actin cytoskeleton rearrangement and Epithelial-Mesenchymal transition process. These findings imply that targeting PLCB1 may be a potential strategy to improve the prognosis of gastric cancer patients.
AuthorsYulin Wang, Zhiyue Tu, Wei Zhao, Liping Wang, Jing Jiang, Lili Gu, Meng Li, Lujian Jiang, Yibin Wang, Yinglu Bi
JournalBiochemical genetics (Biochem Genet) Vol. 61 Issue 6 Pg. 2618-2632 (Dec 2023) ISSN: 1573-4927 [Electronic] United States
PMID37208557 (Publication Type: Journal Article)
Copyright© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Chemical References
  • PLCB1 protein, human
  • Phospholipase C beta
Topics
  • Humans
  • Cell Movement
  • Stomach Neoplasms (genetics, pathology)
  • Phospholipase C beta (genetics)
  • Epithelial-Mesenchymal Transition
  • Actin Cytoskeleton
  • Neoplasm Invasiveness
  • Male
  • Female
  • Middle Aged
  • Cell Line, Tumor
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: